Beijing, China

Guannan Su

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guannan Su. Retrieved from https://idiyas.com/inventor/guannan-su

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guannan Su: Innovator in Cell Reprogramming

Introduction

Guannan Su is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cell reprogramming, particularly through his innovative methods that enhance the cultivation of cells.

Latest Patents

Guannan Su holds a patent for "Reprogramming cells by three-dimensional cultivation." This patent outlines methods for reprogramming cells by culturing them under conditions that facilitate the formation of three-dimensional cell aggregates. The techniques described in this patent provide valuable insights into the manipulation of cellular structures for various applications.

Career Highlights

Guannan Su is affiliated with the Chinese Academy of Sciences, where he conducts research and development in cellular biology. His work has garnered attention for its potential applications in regenerative medicine and biotechnology.

Collaborations

Some of his notable coworkers include Yannan Zhao and Jianshu Wei, who collaborate with him on various research projects.

Conclusion

Guannan Su's innovative work in cell reprogramming exemplifies the advancements being made in cellular biology. His contributions are paving the way for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…